1066 Stock Overview
Engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Shandong Weigao Group Medical Polymer Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$6.01 |
| 52 Week High | HK$6.54 |
| 52 Week Low | HK$3.60 |
| Beta | 0.50 |
| 1 Month Change | 4.34% |
| 3 Month Change | 20.93% |
| 1 Year Change | 11.92% |
| 3 Year Change | -24.12% |
| 5 Year Change | -56.45% |
| Change since IPO | 3,384.06% |
Recent News & Updates
Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly
May 06
Analysts Are Updating Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Estimates After Its Annual Results
Mar 28Recent updates
Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly
May 06Analysts Are Updating Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Estimates After Its Annual Results
Mar 28Pinning Down Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) P/E Is Difficult Right Now
Mar 10Shandong Weigao Group Medical Polymer (HKG:1066) Is Reinvesting At Lower Rates Of Return
Feb 07Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?
Nov 26Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital
Nov 04Analysts Have Been Trimming Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Price Target After Its Latest Report
Sep 24Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Just Reported, And Analysts Assigned A HK$6.74 Price Target
Aug 30Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk
Jun 25Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return
Jun 23Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year
May 31We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope
May 22Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Apr 23Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results
Mar 28Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon
Jan 09Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)
Dec 22Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?
Nov 10Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?
Oct 05Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing
Aug 01Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?
Jul 19Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth
Jun 22Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?
Jun 09The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing
Apr 27Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth
Mar 17A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
Feb 27Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes
Jan 18Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?
Dec 12Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate
Nov 29Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today
Nov 14Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year
Oct 03The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing
Sep 21Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt
Sep 05Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price
Aug 23Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors
Aug 08There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital
Jun 22Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year
Jun 08An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued
May 16Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?
May 03Shareholder Returns
| 1066 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | 3.8% | -0.7% | 2.1% |
| 1Y | 11.9% | 4.6% | 12.6% |
Return vs Industry: 1066 exceeded the Hong Kong Medical Equipment industry which returned 6% over the past year.
Return vs Market: 1066 underperformed the Hong Kong Market which returned 13% over the past year.
Price Volatility
| 1066 volatility | |
|---|---|
| 1066 Average Weekly Movement | 7.5% |
| Medical Equipment Industry Average Movement | 9.6% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in HK Market | 15.5% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 1066 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 1066's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 12,719 | Rinan Cong | www.weigaogroup.com |
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China. It operates through Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products, and Others segments. The Medical Device Products segment includes safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation system, and extracorporeal circulation solutions.
Shandong Weigao Group Medical Polymer Company Limited Fundamentals Summary
| 1066 fundamental statistics | |
|---|---|
| Market cap | HK$27.44b |
| Earnings (TTM) | HK$2.24b |
| Revenue (TTM) | HK$14.17b |
12.3x
P/E Ratio1.9x
P/S RatioIs 1066 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1066 income statement (TTM) | |
|---|---|
| Revenue | CN¥13.09b |
| Cost of Revenue | CN¥6.55b |
| Gross Profit | CN¥6.54b |
| Other Expenses | CN¥4.47b |
| Earnings | CN¥2.07b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.45 |
| Gross Margin | 49.94% |
| Net Profit Margin | 15.79% |
| Debt/Equity Ratio | 15.8% |
How did 1066 perform over the long term?
See historical performance and comparisonDividends
3.9%
Current Dividend Yield47%
Payout RatioDoes 1066 pay a reliable dividends?
See 1066 dividend history and benchmarks| Shandong Weigao Group Medical Polymer dividend dates | |
|---|---|
| Ex Dividend Date | Jun 02 2025 |
| Dividend Pay Date | Jul 11 2025 |
| Days until Ex dividend | 19 days |
| Days until Dividend pay date | 58 days |
Does 1066 pay a reliable dividends?
See 1066 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/13 00:41 |
| End of Day Share Price | 2025/05/13 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Shandong Weigao Group Medical Polymer Company Limited is covered by 33 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jason Mann | Barclays |
| Derrick Sun | BNP Paribas Securities (Asia) |
| Jessica Li | BofA Global Research |